This is the authors' abstract. We don't add key points for this paper.
The synthesis and photophysical characterization of a series of tetradentate cyclometalated M( tzp Ph-O-CzPy-R) complexes and their analogues are reported, where M is palladium or platinum and a tetradentate cyclometalating ligand contains tzp Ph (3-phenyl-[1,2,4]triazolo[4,3- a ]pyridine) and CzPy (carbazolylpyridine) moieties linked with an oxygen atom. Variations of the σ-electron-donating group R on the ligand significantly affect the photophysical properties of the complexes. By using the strong electron-withdrawing tzp portion as an acceptor and the carbazole portion as a donor, a series of Pd(II)-based metal-assisted delayed fluorescence (MADF) materials was developed. Electrochemical analysis demonstrates the irreversible reduction process occurs on the tzp ring and the irreversible oxidation process mainly occurs on the metal-phenyl moiety. This is in agreement with the HOMO and LUMO distributions by the DFT calculations, which also shows that the Pt(II) complex has more metal orbital character than those of the Pd(II) complexes. Most of the Pd(II) complexes reported here are highly emissive at 77 K in 2-MeTHF with luminescent lifetimes in the millisecond range (τ = 1.96–2.36 ms) and λ max = 488–499 nm; however, the luminescent lifetimes are shortened to the microsecond range (τ = 26.7–152.9 μs in solution and 57.0–109.9 μs in thin film respectively) at room temperature. The quantum efficiency of the Pd(II) complexes can be increased by more than 8-fold through structure modification with σ-donating groups on the ligand. Especially, the Pd( tzp -3) has a small Δ E ST of 0.228 eV and exhibits strong typical MADF in PMMA film. The Pt(II) complex Pt( tzp -2) exhibits high thermal stability (Δ T 0.5% = 440 °C) and high quantum efficiency (Φ = 50.1%) in dichloromethane solution with τ of 15.8 μs. The Pt( tzp -2) based bright green OLED achieved a peak EQE of 8.7% and a maximum brightness of 28280 cd/m 2 using an unoptimized device structure.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: